Dry Eye Disease (DED)
Contact us for a free consultation!
DRY EYE DISEASE
Platelet-Rich Plasma (PRP) therapy is emerging as a promising treatment for Dry Eye Disease (DED), particularly in patients who do not respond to conventional treatments. PRP is an autologous (from your own blood) biological product that is rich in growth factors and anti-inflammatory proteins, which can promote tissue regeneration and healing.
DED
How PRP Works for Dry Eye Disease
-
Enhancing tissue repair: Growth factors (e.g., platelet-derived growth factor, transforming growth factor) promote healing of damaged ocular surface tissues.
-
Reducing inflammation: Anti-inflammatory cytokines can reduce ocular surface inflammation.
-
Improving tear film stability: PRP helps restore the balance of tears by promoting the regeneration of the lacrimal (tear-producing) glands and stabilizing the tear film.
-
Epithelial healing: Accelerates the repair of corneal and conjunctival microdamage.
The PRP Procedure for Dry Eye Disease
-
Blood Draw: A small amount of the patient's blood is drawn.
-
Centrifugation: The blood is spun in a centrifuge to separate the platelet-rich plasma from other components.
-
Preparation of Eye Drops: The PRP is diluted (usually with saline) to create eye drops.
-
Application: The patient applies the PRP eye drops several times a day, similar to artificial tears.
Efficacy of PRP for Dry Eye
-
Significantly reduce symptoms like burning, dryness, and light sensitivity.
-
Improve objective signs like tear breakup time (TBUT) and ocular surface staining.
-
Can promote long-term improvement when used consistently.
Who Might Benefit from PRP?
-
Patients with severe or refractory dry eye unresponsive to artificial tears or medications.
-
Individuals with ocular surface diseases like Sjögren’s syndrome, graft-versus-host disease (GVHD), or chemical burns.
Free consultation
We encourage our clients to make an initial contact to make sure you receive all the necessary information before booking in an appointment.